Brind.

Sales growth for Cytosorbents was driven by Germany on August 14, 2025.

1 report, 1 independent Updated Aug 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Cytosorbents

Keep exploring

The entities involved

Cytosorbents
company
- Cytosorbents regained the minimum bid price requirement of $1.00 per share on Nasdaq and is advancing its DrugSorb-ATR product toward FDA regulatory approval.Wed 12:13

Related events

Cytosorbents held an investor conference in New York City.Sep 10

Coverage

Newest first; wire copies grouped

Aug 14Zacks Small Cap ResearchCTSO: CytoSorbents High Margin Revenue Growth Supports Price Target of $4.00. By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT 2nd Quarter 2025 Financial & Operating Results On Augu